Currently, nearly 10 million (1 in 4) patients with diabetes have diabetic retinopathy (DR) in the United States, with 5% (1.84 million) having vision-threatening disease
As commercial supply stabilizes, patients should transition to FDA-approved treatments and consult their providers for guidance
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
El Wegovy se ha ensayado con xito en personas con sobrepeso y obesidad, obtenindose unos resultados de prdida de peso de hasta un 15%, a los 5 a 6 meses del tratamiento
How to Choose Your Optimal Injection Day Select a day that coincides with an existing weekly routinea standing meeting, weekend ritual, or day offso the injection becomes automatic
Your plan may include: Individual therapy gives you dedicated one-to-one time with a specialist psychological therapist